---
$id: https://graph.org.ai/products/commodity/51283002
$type: Product
source: UNSPSC
code: "51283002"
title: "Clindamycin"
class: "51283000"
classTitle: "Lincosamides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Clindamycin

**UNSPSC Code**: 51283002
**Class**: [Lincosamides](Lincosamides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a lincosamide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3U02EL437C. European Medicines Agency schedules Clindamycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06665MIG. Clindamycin generally arises in the molecular formula C18H33CLN2O5S. The term CLINDAMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 23, no. 10 1969, list 9.) CLINDAMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule clindamycin under HS 29419000 and SITC 54139. As of Q4 2014, CLINDAMYCIN remains the US FDA Preferred Term for this commodity. Clindamycin bears US NLM identifiers UMLS ID C0008947 and NCI Concept Code C377. SMILES: CLC(C(NC(=O)C1N(CC(C1)CCC)C)C1OC(SC)C(O)C(O)C1O)C.

